US federal regulators are reviving the dormant HIPAA compliance audit program, last used in 2017, to strengthen healthcare sector cybersecurity. The Department of Health and Human Services (HHS) will initiate audits later in the year and evaluate compliance with potential HIPAA security rule changes. A 39-question online survey involving past HIPAA auditees will assess the past audits' effectiveness and the entities' post-audit compliance actions.

They're Back: HHS OCR Plans Resurrect Random HIPAA Audits BankInfoSecurity

Meta's Chief AI Scientist Yann LeCun discusses challenges to achieve Artificial General Intelligence (AGI), Meta's open-source philosophy, and dismisses existential risk claims. LeCun asserts that increasing data and computing power won't lead to AGI as current AI systems lack understanding of the physical world and can't plan beyond their training. He also argues that full intelligence isn't necessary for AI, instead championing incremental advancement towards 'cat-level' intelligence. LeCun supports AI development in an open-source environment, emphasizing AI's future role mediating our digital interaction and information sources. On AI security risks, LeCun counters that well-designed AIs can overpower ill-intentioned AIs. He also calls the idea of AI dominance 'fallacy' and 'preposterous'.

Meta’s AI Chief Yann LeCun on AGI, Open-Source, and AI Risk Time

OpenAI upgrades chatbot ChatGPT, introducing persistent memory, enabling app to recall user info across different sessions. Initially available to selected free and paid users; useful in work and personal contexts. Memory can be managed and deleted; concerns over bias and sensitive info being addressed. Future roll-out expected for Enterprise and Teams users, as competition in AI assistance heightens.

OpenAI upgrades ChatGPT with persistent memory and temporary chat VentureBeat

23andMe, once valued at $6 billion, now risks Nasdaq delisting with valuation down 98%, under $1 stock; CEO Wojcicki's billions lost; staff reduced 25% via layoffs, subsidiary sale; company unprofitable, may exhaust cash by 2025.

23andMe’s Fall From $6 Billion to Nearly $0 - WSJ WSJ